Literature DB >> 19266593

Influence of genes, sex, age and environment on the onset of autoimmune hepatitis.

Kathie Béland, Pascal Lapierre, Fernando Alvarez.   

Abstract

The pathogenesis of autoimmune hepatitis (AIH) is complex. However, it is believed that a susceptible individual, owing to his genetic background, sex and age, can develop the disease following exposure to an environmental trigger. Autoimmune hepatitis does not follow a Mendelian pattern of inheritance; hence no single causative genetic locus has been identified. However, several genes, inside and outside the HLA locus, have been linked to an increased susceptibility to AIH. Epidemiological evidence also suggests that the sex and age of the patient plays a role in AIH pathogenesis as the disease onset occurs mainly in the two first decades of life and a higher disease incidence is observed in females. No environmental trigger has been identified, but several have been proposed, mainly viruses and xenobiotics. This article aims at reviewing the current knowledge on susceptibility factors leading to AIH and putative triggers, emphasizing fundamental mechanisms responsible for the break of liver immunological tolerance.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19266593      PMCID: PMC2655185          DOI: 10.3748/wjg.15.1025

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  107 in total

1.  Chronic hepatitis in an infant, in association with human herpesvirus-6 infection.

Authors:  H Tajiri; K Tanaka-Taya; Y Ozaki; S Okada; S Mushiake; K Yamanishi
Journal:  J Pediatr       Date:  1997-09       Impact factor: 4.406

2.  Testosterone therapy ameliorates experimental autoimmune encephalomyelitis and induces a T helper 2 bias in the autoantigen-specific T lymphocyte response.

Authors:  M Dalal; S Kim; R R Voskuhl
Journal:  J Immunol       Date:  1997-07-01       Impact factor: 5.422

3.  Autoimmune hepatitis in childhood: a 20-year experience.

Authors:  G V Gregorio; B Portmann; F Reid; P T Donaldson; D G Doherty; M McCartney; A P Mowat; D Vergani; G Mieli-Vergani
Journal:  Hepatology       Date:  1997-03       Impact factor: 17.425

4.  Autoimmune hepatitis and adrenal insufficiency in an infant with human herpesvirus-6 infection.

Authors:  K Schmitt; J Deutsch; G Tulzer; R Meindi; S Aberle
Journal:  Lancet       Date:  1996-10-05       Impact factor: 79.321

5.  Allelic basis for HLA-encoded susceptibility to type 1 autoimmune hepatitis.

Authors:  M D Strettell; P T Donaldson; L J Thomson; P J Santrach; S B Moore; A J Czaja; R Williams
Journal:  Gastroenterology       Date:  1997-06       Impact factor: 22.682

6.  Autoimmune hepatitis type 2 and hepatitis C virus infection: study of HLA antigens.

Authors:  A Jurado; B Cárdaba; P Jara; P Cuadrado; L Hierro; B de Andrés; V del Pozo; M I Cortegano; S Gallardo; C Camarena; R Bárcena; J L Castañer; R Alvarez; C Lahoz; P Palomino
Journal:  J Hepatol       Date:  1997-05       Impact factor: 25.083

7.  Influence of donor and recipient gender on the outcome of liver transplantation.

Authors:  B K Brooks; M F Levy; L W Jennings; O Abbasoglu; M Vodapally; R M Goldstein; B S Husberg; T A Gonwa; G B Klintmalm
Journal:  Transplantation       Date:  1996-12-27       Impact factor: 4.939

8.  Genetic distinctions between types 1 and 2 autoimmune hepatitis.

Authors:  A J Czaja; M Kruger; P J Santrach; S B Moore; M P Manns
Journal:  Am J Gastroenterol       Date:  1997-12       Impact factor: 10.864

Review 9.  Autoimmune hepatitis triggered by administration of an herbal medicine.

Authors:  T Kamiyama; T Nouchi; S Kojima; N Murata; T Ikeda; C Sato
Journal:  Am J Gastroenterol       Date:  1997-04       Impact factor: 10.864

10.  Hepatitis B virus carrier status linked to autoimmune hepatitis.

Authors:  C Murakami; K Hino; M Okazaki; K Fujii; M Okuda; H Hanada; T Yamasaki; K Okita
Journal:  Intern Med       Date:  1996-06       Impact factor: 1.271

View more
  9 in total

1.  Preventive effects of 1,25-(OH)2VD3 against ConA-induced mouse hepatitis through promoting vitamin D receptor gene expression.

Authors:  Xu-dong Hu; Shi-li Jiang; Cheng-hai Liu; Yi-yang Hu; Cheng Liu; Ming-yu Sun; Gao-feng Chen; Ping Liu
Journal:  Acta Pharmacol Sin       Date:  2010-06       Impact factor: 6.150

Review 2.  Regulatory T Cells in Autoimmune and Viral Chronic Hepatitis.

Authors:  Pascal Lapierre; Alain Lamarre
Journal:  J Immunol Res       Date:  2015-05-28       Impact factor: 4.818

3.  Hyperferritinemia and hypergammaglobulinemia predict the treatment response to standard therapy in autoimmune hepatitis.

Authors:  Richard Taubert; Matthias Hardtke-Wolenski; Fatih Noyan; Claudine Lalanne; Danny Jonigk; Jerome Schlue; Till Krech; Ralf Lichtinghagen; Christine S Falk; Verena Schlaphoff; Heike Bantel; Luigi Muratori; Michael P Manns; Elmar Jaeckel
Journal:  PLoS One       Date:  2017-06-08       Impact factor: 3.240

4.  Autoimmune hepatitis-like disease in C57BL/6 mice infected with mouse hepatitis virus A59.

Authors:  José L Aparicio; Clara Peña; Lilia A Retegui
Journal:  Int Immunopharmacol       Date:  2011-05-31       Impact factor: 4.932

Review 5.  Environmental exposure as a risk-modifying factor in liver diseases: Knowns and unknowns.

Authors:  Juliane I Beier; Gavin E Arteel
Journal:  Acta Pharm Sin B       Date:  2021-09-10       Impact factor: 11.413

6.  Nosocomial infections in female compared with male patients with decompensated liver cirrhosis.

Authors:  Marie Griemsmann; Tammo L Tergast; Nicolas Simon; Abdul-Rahman Kabbani; Michael P Manns; Heiner Wedemeyer; Markus Cornberg; Benjamin Maasoumy
Journal:  Sci Rep       Date:  2022-02-28       Impact factor: 4.996

Review 7.  Type 2 autoimmune hepatitis: Genetic susceptibility.

Authors:  Pascal Lapierre; Fernando Alvarez
Journal:  Front Immunol       Date:  2022-09-29       Impact factor: 8.786

8.  Liver restores immune homeostasis after local inflammation despite the presence of autoreactive T cells.

Authors:  Kathie Béland; Pascal Lapierre; Idriss Djilali-Saiah; Fernando Alvarez
Journal:  PLoS One       Date:  2012-10-24       Impact factor: 3.240

9.  Divergent effects of RIP1 or RIP3 blockade in murine models of acute liver injury.

Authors:  M Deutsch; C S Graffeo; R Rokosh; M Pansari; A Ochi; E M Levie; E Van Heerden; D M Tippens; S Greco; R Barilla; L Tomkötter; C P Zambirinis; N Avanzi; R Gulati; H L Pachter; A Torres-Hernandez; A Eisenthal; D Daley; G Miller
Journal:  Cell Death Dis       Date:  2015-05-07       Impact factor: 8.469

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.